153 related articles for article (PubMed ID: 31974445)
1. Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer.
Misawa K; Mima M; Satoshi Y; Misawa Y; Imai A; Mochizuki D; Nakagawa T; Kurokawa T; Oguro M; Ishikawa R; Yamaguchi Y; Endo S; Kawasaki H; Kanazawa T; Mineta H
Sci Rep; 2020 Jan; 10(1):1007. PubMed ID: 31974445
[TBL] [Abstract][Full Text] [Related]
2. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
3. Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation.
Misawa K; Mima M; Satoshi Y; Imai A; Mochizuki D; Ishikawa R; Kita J; Yamaguchi Y; Endo S; Misawa Y; Mineta H
J Transl Med; 2020 Jan; 18(1):31. PubMed ID: 31969157
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
[TBL] [Abstract][Full Text] [Related]
6. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
[TBL] [Abstract][Full Text] [Related]
7. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancers.
Avincsal MO; Jimbo N; Fujikura K; Shinomiya H; Otsuki N; Morimoto K; Furukawa T; Morita N; Maehara R; Itoh T; Nibu KI; Zen Y
Histopathology; 2018 Apr; 72(5):826-837. PubMed ID: 29143365
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
[TBL] [Abstract][Full Text] [Related]
12. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
[TBL] [Abstract][Full Text] [Related]
13. Association of TET3 epigenetic inactivation with head and neck cancer.
Misawa K; Imai A; Mochizuki D; Mima M; Endo S; Misawa Y; Kanazawa T; Mineta H
Oncotarget; 2018 May; 9(36):24480-24493. PubMed ID: 29849955
[TBL] [Abstract][Full Text] [Related]
14. Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis.
Misawa K; Imai A; Mochizuki D; Misawa Y; Endo S; Hosokawa S; Ishikawa R; Mima M; Shinmura K; Kanazawa T; Mineta H
Oncotarget; 2017 Sep; 8(44):76318-76328. PubMed ID: 29100314
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A
Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
[TBL] [Abstract][Full Text] [Related]
19. Frequent promoter hypermethylation associated with human papillomavirus infection in pharyngeal cancer.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Takane K; Fukuyo M; Rahmutulla B; Shinohara KI; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Nakatani Y; Okamoto Y; Kaneda A
Cancer Lett; 2017 Oct; 407():21-31. PubMed ID: 28823962
[TBL] [Abstract][Full Text] [Related]
20. Investigation of GHSR and GHRL methylation in colorectal cancer.
Coppedè F; Stoccoro A; Lazzarotti A; Spisni R; Migliore L
Epigenomics; 2018 Dec; 10(12):1525-1539. PubMed ID: 29963901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
